- Home
- KMPR vs AAPG Comparison
KMPR vs AAPG Comparison
Compare KMPR & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMPR
- AAPG
- Stock Information
- Founded
- KMPR 1990
- AAPG 2009
- Country
- KMPR United States
- AAPG China
- Employees
- KMPR N/A
- AAPG N/A
- Industry
- KMPR Property-Casualty Insurers
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- KMPR Finance
- AAPG Health Care
- Exchange
- KMPR Nasdaq
- AAPG Nasdaq
- Market Cap
- KMPR 4.2B
- AAPG 4.0B
- IPO Year
- KMPR N/A
- AAPG 2025
- Fundamental
- Price
- KMPR $53.69
- AAPG $41.98
- Analyst Decision
- KMPR Buy
- AAPG Buy
- Analyst Count
- KMPR 4
- AAPG 1
- Target Price
- KMPR $67.50
- AAPG N/A
- AVG Volume (30 Days)
- KMPR 1.2M
- AAPG 9.5K
- Earning Date
- KMPR 08-05-2025
- AAPG 08-20-2025
- Dividend Yield
- KMPR 2.38%
- AAPG N/A
- EPS Growth
- KMPR 562.92
- AAPG N/A
- EPS
- KMPR 5.31
- AAPG N/A
- Revenue
- KMPR $4,784,500,000.00
- AAPG $54,524,554.00
- Revenue This Year
- KMPR $0.77
- AAPG N/A
- Revenue Next Year
- KMPR $6.74
- AAPG $387.72
- P/E Ratio
- KMPR $10.12
- AAPG N/A
- Revenue Growth
- KMPR 2.67
- AAPG N/A
- 52 Week Low
- KMPR $45.02
- AAPG $16.50
- 52 Week High
- KMPR $73.01
- AAPG $48.45
- Technical
- Relative Strength Index (RSI)
- KMPR 43.05
- AAPG N/A
- Support Level
- KMPR $52.63
- AAPG N/A
- Resistance Level
- KMPR $53.85
- AAPG N/A
- Average True Range (ATR)
- KMPR 1.01
- AAPG 0.00
- MACD
- KMPR 0.36
- AAPG 0.00
- Stochastic Oscillator
- KMPR 69.98
- AAPG 0.00
About KMPR Kemper Corporation
Kemper Corp is a diversified insurance company that provides services in property and casualty insurance, along with life and health insurance. The company's property and casualty segment offers personal and commercial lines for home and automotive products. The company conducts its operations through two operating segments: Specialty Property & Casualty Insurance, and Life Insurance.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.